Breviscapin

CAS No. 116122-36-2

Breviscapin ( —— )

Catalog No. M17848 CAS No. 116122-36-2

Breviscapine is the total flavonoid components (the content of scutellarin > or =85%) extracted from the dried whole plant of Erigeron breviscapus.

Purity : 97%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 38 In Stock
100MG 46 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Breviscapin
  • Note
    Research use only, not for human use.
  • Brief Description
    Breviscapine is the total flavonoid components (the content of scutellarin > or =85%) extracted from the dried whole plant of Erigeron breviscapus.
  • Description
    Breviscapine is the total flavonoid components (the content of scutellarin > or =85%) extracted from the dried whole plant of Erigeron breviscapus.
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    RAAS
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    116122-36-2
  • Formula Weight
    908.72
  • Molecular Formula
    C21H18O11
  • Purity
    97%
  • Solubility
    ——
  • SMILES
    c1cc(ccc1c1cc(=O)c2c(c(c(cc2o1)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)C(=O)O)O)O)O)O)O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Xia H, et al. Biol Pharm Bull. 2007 Jul;30(7):1308-16.
molnova catalog
related products
  • Saralasin acetate(34...

    Saralasin acetate is a Non-selective angiotensin II antagonist.

  • Benazepril hydrochlo...

    Benazepril, brand name Lotensin, is a medication used to treat high blood pressure (hypertension), congestive heart failure, and chronic renal failure.

  • Angiotensin II human

    Angiotensin II human is converted by Angiotensin I through removal of two C-terminal residues by the enzyme angiotensin-converting enzyme (ACE).